Company intelligence / Profile preview

Calox de Costa Rica

San José, Costa Rica

Ownership: Private
Employees: ~745
Development stage: Other

Overview

Calox de Costa Rica is a leading pharmaceutical company focusing on the manufacture and commercialization of generic, branded, and over-the-counter medications with a strong regional presence. The company has over 90 years of experience, with a wide-ranging product portfolio for both human and veterinary health, and operates modern, certified manufacturing plants in Costa Rica and Venezuela.

Modalities: Small molecule
Industry: Biotech

Partnerships

Sukia Farmaceutica (Costa Rica) – strategic alliance since 1996

Beyond the preview

Go deeper on Calox de Costa Rica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calox de Costa Rica.

Explore the full profile